Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Effectiveness of case-area targeted interventions including vaccination on the control of epidemic cholera: protocol for a prospective observational study.
RATNAYAKE, R; Peyraud, N; Ciglenecki, I; Gignoux, E; Lightowler, M; Azman, AS; Gakima, P; Ouamba, JP; Sagara, JA; Ndombe, R; Mimbu, N; Ascorra, A; Epicentre and MSF CATI Working Group,; Welo, PO; Mukamba Musenga, E; Miwanda, B; Boum, Y; CHECCHI, F; EDMUNDS, WJ; Luquero, F; Porten, K; Finger, F;
2022
BMJ Open, (2022).12 7 10.1136/bmjopen-2022-061206.
Prevalence of malaria and helminth infections in rural communities in northern Sierra Leone, a baseline study to inform Ebola vaccine study protocols. S1 Data.
Baiden, F; FLECK, S; Leigh, B; Ayieko, P; TINDANBIL, D; Otieno, T; Lawal, B; Tehtor, M; Rogers, M; Odeny, L; Hodges, MH; Sonnie, M; Samai, M; Ishola, D; Lowe, B; WATSON-JONES, D; GREENWOOD, B;
2022
, PLOS ONE (2022).
Effectiveness of CoronaVac and BNT162b2 COVID-19 mass vaccination in Colombia: A population-based cohort study.
Paternina-Caicedo, A; JIT, M; Alvis-Guzmán, N; Fernández, JC; Hernández, J; Paz-Wilches, JJ; Rojas-Suarez, J; Dueñas-Castell, C; Alvis-Zakzuk, NJ; Smith, AD; Hoz-Restrepo, FD L;
2022
The Lancet Regional Health Americas, (2022).12, 10.1016/j.lana.2022.100296.
Determinants of human papillomavirus (HPV) vaccine uptake among girls in France: A population-based telephone survey.
Dib, F; MAYAUD, P; Renaudie, C; Launay, O; Chauvin, P;
2022
Human vaccines & immunotherapeutics, (2022).18 5 10.1080/21645515.2022.2083894.
The Vaccine-Hesitant Moment.
LARSON, HJ; Gakidou, E; Murray, CJ L;
2022
The New England journal of medicine, (2022).387 1 10.1056/nejmra2106441.
A next generation BCG vaccine moves forward.
DOCKRELL, HM;
2022
The Lancet. Infectious diseases, (2022).22 10 10.1016/s1473-3099(22)00287-0.
Adding to the mantra: vaccines prevent illness and death, and preserve existing antibiotics.
HEYMANN, DL; Kieny, M-P; Laxminarayan, R;
2022
The Lancet. Infectious diseases, (2022).22 8 10.1016/s1473-3099(22)00374-7.
Safety of the Ad26.ZEBOV/MVA-BN-Filo vaccine regimen in adults, children and pregnant women in DRC and immunogenicity of a delayed 2nd dose: the DRC-EB-001 trial.
WATSON-JONES, D;
2022
(2022).
Estimating baseline rates of adverse perinatal and neonatal outcomes using a facility-based surveillance approach: A prospective observational study from the WHO Global Vaccine Safety Multi-Country Collaboration on safety in pregnancy.
Sharan, A; Stuurman, AL; Jahagirdar, S; Elango, V; Riera-Montes, M; Kashyap, NK; Biccler, J; Poluru, R; Arora, NK; Mathai, M; MANGTANI, P; Devlieger, H; Anderson, S; Whitaker, B; Wong, H-L; Moran, A; Maure, CG; WHO Global Vaccine Safety Multi-Country Collaborat,;
2022
EClinicalMedicine, (2022).50, 10.1016/j.eclinm.2022.101506.
The effect of helminth infection on vaccine responses in humans and animal models: A systematic review and meta-analysis.
NATUKUNDA, A; ZIRIMENYA, L; Nassuuna, J; NKURUNUNGI, G; COSE, S; ELLIOTT, AM; WEBB, EL;
2022
Parasite Immunology, (2022).44 9 10.1111/pim.12939.